Business

Laos Tightens Foreign Borrowing Rules as Debt Risks Persist

Laos has tightened controls on foreign borrowing as the government seeks to limit debt risks and reduce pressure on foreign-currency reserves and the Lao kip. Under a new Bank of Laos decision issued in August, individuals and companies must obtain central bank approval before taking certain loans, guarantees, trade credits...

Laos Cuts 7-Day Base Interest Rate to 7% as Economic Risks Persist

The Bank of Laos (BOL) has cut its seven-day base interest rate from 8...

Laos Studies USD 1 Billion Vientiane-Lidu Industrial Park in Pakngum

On 13 August, Laos agreed to study the development of a new industrial park...

Vientiane Halts New Microfinance, Pawnshop Licenses Amid Regulatory Review

On 31 July, the Bank of the Lao PDR (BoL) suspended applications for new...

Lao Authorities, Lao Bank Seek Legal Action Against Thai Media Over Money Laundering Claims

On 31 July, Lao authorities and Lao Development Bank (LDB) met with Thailand's Central...

How the documenta invented the “Zero Hour” in art after 1945

“documenta. Politics and Art” from 18 June 2021 to 9 January 2022  BERLIN, GERMANY - Newsaktuell - 1 March 2021 - The documenta...

Unveiling The Activities of Daily Living (ADL) Care Concept – Live life to the fullest with CERTAINTY

KUALA LUMPUR, MALAYSIA - Media OutReach - 1 March 2021 - CERTAINTY, a brand under Disposable Soft Goods (DSG) has recently unveiled...

FWD Insurance and HKT team up to reward FWD MAX members with exclusive promotions

Members can experience telemedicine video consultation and unparalleled mobile 5G telecommunication services from CSL Mobile HONG KONG SAR - Media OutReach - 1 March 2021...

First Phase of Sithandone SEZ Development Project Underway

When completed, the first phase of the Sithandone Special Economic Zone (SEZ) is expected to be valued at some USD 600 million. According to a...

Fellows Creative Staff Singapore opened their Singapore office to help the creative content of all businesses stand out in the DX era by sourcing...

SINGAPORE - Media OutReach - 1 March 2021 - With everyone stuck at home during the pandemic, more people are exposed to...

Novartis Piqray® – First and only treatment specially for patients with a PIK3CA mutation in HR+/HER2- advanced breast cancer receives HSA approval[1]

Piqray (alpelisib) is the only treatment approved specifically to address PIK3CA mutationThe approval was based on SOLAR-1 Phase III trial showing Piqray plus fulvestrant...